Product Description
The global stent graft market was valued at $2.9 billion in 2025. This is expected to increase over the forecast period at a CAGR of 4.9% to reach $4.1 billion by 2032.
The full report on the global stent graft market includes AAA stent grafts, fenestrated stent grafts, and TAA stent grafts.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Stent Graft Market Trends
An ongoing trend in the peripheral vascular stent market is the growing adoption of drug-eluting stents (DESs) for treating peripheral arterial disease (PAD). These stents are designed to release medication directly at the site of implantation, reducing the risk of restenosis and improving long-term outcomes. The advancement of DES technology has led to improved patency rates and reduced reintervention rates compared to traditional bare-metal stents (BMSs). As clinical evidence continues to support the effectiveness of DESs in peripheral interventions, their adoption is expected to increase, reshaping the landscape of peripheral vascular stent treatments worldwide.
Global Stent Graft Market Share Insights
- W.L. Gore’s strength in the covered stent market comes from the successful development and marketing of its VIABAHN® covered stents. Incremental improvements in the stent, namely a heparin coating and lower profile designs, have paid off. The GORE® TIGRIS® self-expanding vascular stent received Food and Drug Administration (FDA) approval for use in the SFA and proximal popliteal artery (PPA) in 2016.
- Boston Scientific held a strong presence in the iliac and renal stent segments through its Express® LD iliac stent and Express® SD stents. In the venous stenting market, the company is a leading competitor. It leveraged its historical market share with Wallstent™ to successfully introduce the VICI® stent in 2013. With VICI® gaining approval in the U.S. in 2019, Boston Scientific is poised to maintain its robust market positions both domestically and globally in the foreseeable future.
- Abbott held the third-leading position in 2025. The company’s Xience Prime™ BTK stent received a CE mark in 2011 and has captured sizable market share within this category. Abbott Vascular sells a wide variety of devices that are both balloon-expandable and self-expandable. Its stents are used in all peripheral indications.
Global Stent Graft Market Segmentation Summary
- AAA Stent Graft Market
- Fenestrated Stent Graft Market
- TAA Stent Graft Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
